EVALUATION OF CARCINOGENIC RISKS

致癌风险评估

• 批准号: 2667861
• 负责人: JERRY M RICE
• 金额: $ 39.15万
• 依托单位: INTERNATIONAL AGENCY FOR RES ON CANCER
• 依托单位国家: 美国
• 财政年份: 1985
• 资助国家: 美国
• 起止时间: 1985-09-01 至 2000-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2667861
• 关键词: cancer risk; carcinogen testing; chemical carcinogen; chemical information system; health science research analysis /evaluation; information dissemination; international health /scientific organization; literature survey; monograph

The objective of the IARC Program on the Evaluation of Carcinogenic Risks to Humans is to identify on the basis of all published epidemiological and experimental data exposures to chemicals, complex mixtures, and physical and biological factors and exposure circumstances which may pose a carcinogenic risk to humans, and to publish these evaluated data in the form of IARC Monographs. The Preamble to the IARC Monographs defines the guiding principles in making evaluations of carcinogenicity on the basis of results from epidemiological studies, long-term carcinogenicity studies in animals and other relevant data (e.g., toxicity, metabolism, genotoxicity and mechanistic studies). Priorities for future monographs topics have been established by ad-hoc Working Groups. Since new topics for evaluation will be chosen in part on the basis of future publication of experimental findings, the program also monitors on-going carcinogenicity testing worldwide through the Directory of Agents Being Tested for Carcinogenicity. A Directory of On-Going Research on Cancer Epidemiology is also produced by the Agency. Each volume of IARC Monographs results from the deliberations of an international Working Group of 15-20 experts in epidemiology, experimental carcinogenesis and related disciplines which meets in Lyon for one week; three meetings are held each year. Monographs are distributed to Governments, Regulatory Agencies and interested scientists; they are available via the WHO Distribution and Sales Service. The summarized and evaluated data can be used as an element on which priorities for preventive measures will be decided. The Monographs and related databases will also be available on an IARCancer CD-ROM. The Directory is produced every two years based upon the replies received to survey questionnaires. They are distributed to all collaborating laboratories and governments with the aim of reducing duplication of effort and improving communication between scientists in the area of carcinogenicity testing in animals. The International Agency for Research on Cancer has adequate facilities for meetings and the production of monographs. Scientific staff includes scientists from many different countries who can assist in the evaluation of international scientific literature and provide scientific guidance for the Working Groups.

IARC 致癌风险评估计划的目标 对人类的影响是根据所有已发表的流行病学和 实验数据暴露于化学品、复杂混合物和物理 以及可能造成的生物因素和暴露环境 对人类的致癌风险，并将这些评估数据发布在 IARC 专着的形式。 IARC 专着的序言定义了 致癌性评价的指导原则 流行病学研究、长期致癌性研究的结果 动物和其他相关数据（例如毒性、代谢、 遗传毒性和机制研究）。 未来专着的优先事项 主题由特设工作组确定。 自从有了新话题 评估的部分选择将基于未来的出版 根据实验结果，该计划还监控正在进行的 通过代理目录进行全球致癌性测试 经过致癌性测试。 正在进行的癌症研究目录 流行病学也由该机构制作。 IARC 专着的每卷都是经过审议的结果 由 15-20 名流行病学、实验专家组成的国际工作组 致癌作用及相关学科在里昂举行为期一周的会议； 每年召开三次会议。专着分发给 政府、监管机构和感兴趣的科学家；他们是 可通过世界卫生组织分销和销售服务处获取。 总结和 评估的数据可以用作确定优先级的元素 将决定预防措施。 专着及相关数据库 也将在 IARCancer CD-ROM 上提供。 该名录根据收到的答复每两年制作一次 进行调查问卷。它们被分发给所有协作者 实验室和政府，旨在减少重复 努力并改善该领域科学家之间的交流 动物致癌性试验。 国际癌症研究机构拥有充足的设施 用于会议和专着的制作。 科研人员包括 来自许多不同国家的科学家可以协助评估 国际科学文献并提供科学指导 工作组。